Raleigh, N.C. — Clinical research organization PRA International is expanding its operations in Asia through a partnership with a Taiwan-based firm.
PRA, which provides a variety of services to life science and medical firms, will work through its Taiwan subsidiary with LSK Global Pharma Services and Mediscience Planning.
Financial terms were not disclosed.
The deal gives PRA access to markets in Japan and South Korea.
"Through this collaboration, we are strongly positioned to meet the growing demand for pan-Asian clinical trials,” said PRA Executive Vice President Susan Stansfield.
PRA maintains 32 offices around the world and focuses on oncology, central nervous system, respiratory/allergy, cardiovascular and infectious diseases.
Clinical research organization PRA International expands Asian presence
Copyright 2009 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Jul. 3, 2009 - As Nortel’s final demise nears, what blame should its board shoulder?
Jul. 3, 2009 - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Jul. 3, 2009 - 20/20: Surgery can let you see like a child again
Jul. 3, 2009 |
- CDC: US swine flu cases rise to nearly 34,000
Jul. 3, 2009
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement



